TownSquare Capital’s Antares Pharma, Inc. ATRS Stock Holding History

TownSquare Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-126,526	Closed	-$519K	–	795
2022 Q1	$519K	Sell	126,526 -28,647	-18%	-$104K	0.01%	486
2021 Q4	$554K	Buy	155,173 +46,699	+43%	+$163K	0.01%	467
2021 Q3	$395K	Buy	108,474 +44,309	+69%	+$179K	0.01%	498
2021 Q2	$295K	Buy	+64,165	New	+$261K	0.01%	501

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TownSquare Capital's ATRS Position: Q2 2022 in Review

TownSquare Capital sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 126,526 shares — an estimated $519K sold.

TownSquare Capital first reported a position in ATRS in Q2 2021 and held it in 4 quarters. The position peaked at $554K in Q4 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

TownSquare Capital reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
TownSquare Capital sold 126,526 Antares Pharma, Inc. shares in Q2 2022, an estimated $519K.
TownSquare Capital first reported a position in Antares Pharma, Inc. in Q2 2021 and held it in 4 quarters.
TownSquare Capital's Antares Pharma, Inc. position peaked at $554K in Q4 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on TownSquare Capital's 13F filing for Q2 2022, filed 8 Aug 2022.